Invesco Ltd. Altimmune, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Altimmune, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 31,711 shares of ALT stock, worth $261,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,711

Previous 30,743 3.15%

Holding current value

$261,615

Previous $204,000 4.9%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.5 - $8.1 $5,324 - $7,840	968 Added 3.15%	31,711 $194,000
Q2 2024 Aug 13, 2024	BUY	$5.91 - $10.23 $17,647 - $30,546	2,986 Added 10.76%	30,743 $204,000
Q1 2024 May 14, 2024	SELL	$8.22 - $13.81 $5.91 Million - $9.92 Million	-718,424 Reduced 96.28%	27,757 $282,000
Q4 2023 Feb 12, 2024	BUY	$2.14 - $11.62 $1.53 Million - $8.29 Million	713,152 Added 2159.17%	746,181 $8.39 Million
Q3 2023 Nov 13, 2023	BUY	$2.4 - $3.45 $11,894 - $17,098	4,956 Added 17.65%	33,029 $85,000
Q2 2023 Aug 11, 2023	BUY	$3.45 - $5.97 $96,851 - $167,595	28,073 New	28,073 $99,000
Q4 2022 Feb 13, 2023	BUY	$8.74 - $16.45 $3.72 Million - $7.01 Million	425,849 New	425,849 $7.01 Million
Q2 2022 Aug 15, 2022	SELL	$3.94 - $11.77 $48,532 - $144,982	-12,318 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.9 - $9.45 $2,873 - $4,602	487 Added 4.12%	12,318 $75,000
Q4 2021 Feb 14, 2022	SELL	$8.69 - $12.48 $9,637 - $13,840	-1,109 Reduced 8.57%	11,831 $108,000
Q3 2021 Nov 15, 2021	BUY	$8.43 - $16.81 $21,091 - $42,058	2,502 Added 23.97%	12,940 $147,000
Q2 2021 Aug 17, 2021	SELL	$9.85 - $16.46 $3.96 Million - $6.62 Million	-402,385 Reduced 97.47%	10,438 $103,000
Q1 2021 May 17, 2021	SELL	$12.71 - $24.31 $3.72 Million - $7.11 Million	-292,575 Reduced 41.48%	412,823 $5.83 Million
Q4 2020 Feb 16, 2021	BUY	$7.84 - $14.22 $2.11 Million - $3.83 Million	269,439 Added 61.8%	705,398 $7.96 Million
Q3 2020 Nov 16, 2020	BUY	$9.93 - $33.26 $2.05 Million - $6.86 Million	206,300 Added 89.83%	435,959 $5.75 Million
Q2 2020 Aug 14, 2020	BUY	$2.9 - $10.71 $666,011 - $2.46 Million	229,659 New	229,659 $2.46 Million

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $404M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account